Role of plasma-exchange in the management of patients with factor VIII inhibitors
Tóm tắt
Plasma-exchange is one of many treatments available for the prevention and management of hemorrhage in patients with factor VIII inhibitors. Details of exchange technique and the frequency of treatment are determined by the clinical situation, venous access and the availability of equipment, staff and blood products. In view of the many difficulties associated with plasma-exchange, other treatment options are likely to be preferred in most circumstances. The technique, remains attractive as a means for reducing inhibitory activity before elective surgery and during life-threatening hemorrhage.
Tài liệu tham khảo
Abildgaard C. F., Penner J. A., Watson-Williams E. J.: Anti-inhibitor coagulant complex (Autoplex) for treatment of factor VIII inhibitors in haemophilia—Blood56, 978, 1980.
Austen D. E. G., Rhymes I. L.: A laboratory manual of blood coagulation—Blackwell Sci. Publ., Oxford, 1975.
Biggs R.: Jaundice and antibodies directed against factors VIII and IX in patients treated for haemophilia, or Christmas disease in the United Kingdom—Brit. J. Haemat.26, 313, 1974.
Blatt P. M., Ménaché D., Roberts H. R.: A survey of the effectiveness of prothrombin complex concentrates in controlling haemorrhage in patients with haemophilia and antifactor VIII antibodies—Thrombos. Haemost.44, 39, 1980.
Bloom A. L.: Factor VIII inhibitors revisited— Brit. J. Haemat.49, 319, 1981.
Bloom A. L., Hutton R. D.: Fresh-platelet transfusions in haemophiliac patients with factor VIII antibody—Lancetii, 369, 1975.
Chirnside A., Urbaniak S. J., Prowse C. V., Keller A. J.: Coagulation abnormalities followin intensive plasma exchange on the cell separator—Brit. J. Haemat.48, 627, 1981.
Cobcroft R., Tamagnini G., Dormandy K. M.: Serial plasmapheresis in a haemophiliac with antibodies to FVIII—J. clin. Path.30, 763, 1977.
Erskine J. G.: Plasma exchange in patients with inhibitors, to factor VIIIC—Plasma Ther. Transfus. Tech.3, 123, 1982.
Erskine J. G., Burnett A. K., Walker I. D., Davidson J. F.: Plasma exchange in nonhaemophiliac patients with inhibitors to factor VIIIC—Brit. med. J.283, 760, 1981.
Erskine J. G., Davidson J. F.: Anaphylactic reaction to low molecular weight porcine factor VIII concentrates—Brit. med. J.282, 2011, 1981.
Evans R. T., MacDonald R., Robinson A.: Suxamethonium apnoea associated with plasmapheresis —Anaesthesia35, 198, 1980.
Flaum M. A., Cuneo R. A., Appelbaum F. R., Deiseroth A. B., Engel W. K., Gralnick H. R.: The haemostatic imbalance of plasma exchange transfusion—Blood54, 694, 1979.
Francesconi M., Korninger C., Thaler E., Niessner H., Höcker P., Lechner, K.: Plasmapheresis: its value in the management, of patients with antibodies to factor VIII—Haemostasis11, 79, 1982.
Green D., Lechner K.: A survey of 215 non-hemophilic patients with inhibitors to factor VIII—Thrombos. Haemost.45, 200, 1981.
Hewitt P., Mackie I. J., Machin S. J.: Highly purified porcine factor VIII in haemophilia A —Lanceti, 741, 1982.
Hultin M. B., Shapiro S. S., Bowman H. S., Gill F. M., Andrews A. T., Martinez J., Eyster M. E., Sherwood W. C.: Immunosuppressive therapy of factor VIII inhibitors. —Blood48, 95, 1976.
Kasper C. K., Aledort L. M., Counts R. B., Edson J. R., Fratantoni J., Green D., Hampton J. W., Hilgartner M. W., Lazerson J., Levine P. H., McMillan C. W., Pool J. G., Shapiro S. S., Shulman N. R., Van Eys J.: A more uniform measurement of factor VIII inhibitors—Thrombos. Diathes. haemorrh. (Stuttg)34, 869, 1975.
Lusher J. M., Shapiro S. S., Palascak J. E., Rao A. V., Levine P. H., Blatt P. M. and theHaemophilia Study Group: Efficacy of prothrombin-complex concentrates in haemophiliacs with antibodies to factor VIII. A multicenter therapeutic trial—New Engl. J. Med.303, 421, 1980.
Mannucci P. M.: Problems in hemophilia therapy—La Ricerca Clin. Lab.11, 301, 1981.
Mayne E. E., Madden M., Crothers I. S., Ingles T.: Highly purified porcine factor VIII in haemophilia A with inhibitors to factor VIII—Brit. med. J.282, 318, 1981.
Nilsson I. M., Jonsson S., Sundqvist S., Ahlberg A., Bergentz S.: A procedure for removing high titer antibodies by extracorporeal protein-A-sepharose adsorption in haemophilia: substitution therapy and surgery in a patient with haemophilia B and antibodies —Blood58, 38, 1981.
Paterson J. L., Walsh E. S., Hall G. M.: Progressive depletion of plasma cholinesterase during daily plasma exchange—Brit. med. J.ii, 580, 1979.
Pintado T., Taswell H. F., Bowie E. J.: Treatment of life-threatening haemorrhage due to acquired factor VIII inhibitor—Blood46, 535, 1975.
Rizza C. R.: Clinical management of haemophilia—Brit. med. Bull.33, 225, 1977.
Russell J. A., Toy J. L., Powles R. L.: Plasma exchange in malignant paraproteinaemias—Exp. Hemat.5 (Suppl.) 105, 1977.
Shapiro S. S.: Antibodies to blood coagulation factors—Clin. Haemat.8, 207, 1979.
Sjamsoedin L. J. M., Heijnen L., Mauser-Bunschoten E. P., Van Geijlswijk J. L., Van Houwelingen H., Van Asten P., Sixma J. J.: The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with haemophilia A and antibodies to factor VIII—New Engl. J. Med.305, 717, 1981.
Slocombe G. W., Newland A. C., Colvin M. P., Colvin B. T.: The role of intensive plasma exchange in the prevention and management of haemorrhage in patients with inhibitors to factor VIII—Brit. J. Haemat47, 577, 1981.
Strauss H. S.: Acquired circulating anticoagulants in haemophilia A—New. Engl. J. Med.281, 866, 1969.
Wensley R. T., Stevens R. F., Burn A. M., Delamore I. W.: Plasma exchange and human factor VIII concentrate in managing haemophilia A with factor VIII inhibitors— Brit. med. J.281, 1388, 1980.